Agranulocytosis associated with ajmalin therapy.
D000074:Acenocoumarol / Q000627:therapeutic use; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D000404:Ajmaline / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy*; D003975:Diazepam / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009582:Nitrofurantoin / Q000627:therapeutic use; D010946:Plants, Medicinal; D011239:Prednisolone / Q000627:therapeutic use; D011926:Rauwolfia / Q000009:adverse effects*; D013610:Tachycardia / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000404:Ajmaline; D004077:Digoxin; D009582:Nitrofurantoin; D011239:Prednisolone; D000074:Acenocoumarol; D003975:Diazepam